Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis: a sub study of the IIISAS randomised trial

Back

HFA Premium Access

Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis: a sub study of the IIISAS randomised trial

Session: Improving prognosis in aortic valve disease

Topic: Treatment

Speaker: Doctor A. Floe (Oslo, NO)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor August Magnus Stensroed Floe

Oslo University Hospital Rikshospitalet, Oslo (Norway)

0 follower

6 more presentations in this session

Myocardial work predicts left ventricular dysfunction following transcatheter aortic valve replacement in patients with aortic valve stenosis

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Myocardial work assessment for immediate changes in left ventricular function and survival analysis after transcatheter aortic valve replacement

Speaker: Miss A. Moya (Aalst, BE)

Clinical outcomes of non-severe paravalvular leak after transcatheter aortic valve implantation.

Speaker: Doctor B. Lacerda Teixeira (Lisbon, PT)

Predictors of survival in decompensated HfpEF with moderate aortic stenosis

Speaker: Doctor M. Shumkova (Sofia, BG)

Histological tissue characterization of myocardial remodelling in endomyocardial biopsies from patients with severe aortic valvular disease

Speaker: Miss L. Tapia (Pamplona, Navarra, ES)

Access the full session

Improving prognosis in aortic valve disease

Speakers: Doctor A. Floe, Doctor M. Vanderheyden, Miss A. Moya, Doctor B. Lacerda Teixeira, Doctor M. Shumkova...

Access

Video

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources